Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...
Acloproxalap by Aldeyra Therapeutics for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome: Likelihood of Approval
Acloproxalap is under clinical development by Aldeyra Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Cytokine...
Methotrexate by Aldeyra Therapeutics for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Methotrexate is under clinical development by Aldeyra Therapeutics and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData,...